Biomedical Research Centre, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
J Clin Invest. 2010 Dec;120(12):4182-5. doi: 10.1172/JCI45263. Epub 2010 Nov 22.
Nosocomial infections (i.e., infections acquired as a result of treatment in a hospital or health care unit) result in approximately 100,000 deaths and cost more than 25 billion dollars per year in the US alone. These infections are caused primarily by bacteria and affect mainly immunosuppressed patients. However, not all patients acquire infections, and the events leading up to infection are unclear. In this issue of the JCI, Ubeda et al. report how acquisition of one such infection, vancomycin-resistant Enterococcus faecium (VRE), is linked to a shift in the microbial flora following antibiotic treatment. This study highlights the potential for high-throughput sequencing of intestinal microbiota as a means to identify high-risk populations.
医院获得性感染(即由于在医院或医疗单位接受治疗而获得的感染)在美国每年导致约 10 万人死亡,耗费超过 250 亿美元。这些感染主要由细菌引起,主要影响免疫抑制患者。然而,并非所有患者都会感染,感染前的事件尚不清楚。在本期 JCI 中,Ubeda 等人报告了一种此类感染,即万古霉素耐药粪肠球菌(VRE)的获得与抗生素治疗后微生物菌群的转移有关。这项研究强调了高通量肠道微生物测序作为识别高风险人群的一种手段的潜力。